VST
ABBV icon

Van Strum & Towne’s AbbVie ABBV Stock Holding History

Van Strum & Towne’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.4M Sell
38,623
-270
-0.7% -$59.9K 2.45% 12
2025
Q4 		$8.89M Sell
38,893
-759
-2% -$173K 2.49% 12
2025
Q3 		$9.18M Sell
39,652
-1,182
-3% -$241K 2.7% 8
2025
Q2 		$7.58M Sell
40,834
-1,070
-3% -$199K 2.39% 12
2025
Q1 		$8.78M Buy
41,904
+3,012
+8% +$586K 2.95% 10
2024
Q4 		$6.91M Buy
38,892
+7,196
+23% +$1.32M 2.43% 13
2024
Q3 		$6.26M Buy
31,696
+65
+0.2% +$12.1K 2.17% 15
2024
Q2 		$5.43M Sell
31,631
-129
-0.4% -$21.4K 1.97% 16
2024
Q1 		$5.78M Sell
31,760
-240
-0.8% -$41.4K 2.11% 17
2023
Q4 		$4.96M Sell
32,000
-100
-0.3% -$14.6K 1.94% 16
2023
Q3 		$4.78M Sell
32,100
-445
-1% -$65.3K 2.02% 17
2023
Q2 		$4.38M Buy
32,545
+15
+0% +$2.2K 1.81% 19
2023
Q1 		$5.19M Sell
32,530
-175
-0.5% -$26.8K 2.22% 14
2022
Q4 		$5.29M Sell
32,705
-115
-0.4% -$17.6K 2.28% 13
2022
Q3 		$4.41M Sell
32,820
-339
-1% -$48.6K 2.03% 16
2022
Q2 		$5.08M Buy
33,159
+74
+0.2% +$11.3K 2.16% 14
2022
Q1 		$5.36M Buy
33,085
+755
+2% +$110K 2.01% 17
2021
Q4 		$4.38M Buy
32,330
+930
+3% +$110K 1.59% 20
2021
Q3 		$3.39M Buy
31,400
+550
+2% +$62.8K 1.33% 23
2021
Q2 		$3.48M Sell
30,850
-230
-0.7% -$25.9K 1.66% 20
2021
Q1 		$3.36M Buy
31,080
+1,595
+5% +$171K 1.7% 19
2020
Q4 		$3.16M Buy
29,485
+600
+2% +$57.7K 1.76% 18
2020
Q3 		$2.53M Buy
28,885
+195
+0.7% +$18.4K 1.64% 17
2020
Q2 		$2.82M Buy
28,690
+25,560
+817% +$2.25M 1.96% 17
2020
Q1 		$238K Buy
3,130
+234
+8% +$19.9K 0.19% 59
2019
Q4 		$256K Hold
2,896
– – 0.16% 63
2019
Q3 		$219K Buy
+2,896
New +$199K 0.14% 70

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Van Strum & Towne's ABBV Position: Q1 2026 in Review

Van Strum & Towne reduced its AbbVie (ABBV) stake by 0.69% in Q1 2026, selling an estimated $59.9K and leaving 38,623 shares worth $8.4M. The position accounts for 2.45% of the portfolio, ranked #12.

Van Strum & Towne first reported a position in ABBV in Q3 2019 and has held it in 27 quarters since. The position peaked at $9.18M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Van Strum & Towne held 38,623 shares of AbbVie worth $8.4M as of Q1 2026.
  • Van Strum & Towne sold 270 AbbVie shares in Q1 2026, an estimated $59.9K.
  • AbbVie made up 2.45% of Van Strum & Towne's portfolio in Q1 2026, its #12 holding.
  • Van Strum & Towne first reported a position in AbbVie in Q3 2019 and has held it in 27 quarters since.
  • Van Strum & Towne's AbbVie position peaked at $9.18M in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Van Strum & Towne's 13F filing for Q1 2026, filed 7 May 2026.